Helping Cancer Researchers to Uncover Mechanistic Hypotheses to Progress to the Clinic
View video
Clustering analysis of recently approved kinase inhibitors presented at Discovery on Target 2020 – Virtual
September 14, 2020: Hierarchical clustering of kinase inhibitors based on their IC50 [...]
NTRC launches new website: www.residencetimer.com
July 30, 2020: NTRC launches www.residencetimer.com for biochemical assays in drug discovery. [...]
OUR PREMIUM BENEFITS
Integration of cancer biology and big data analysis
Identification of patient selection markers
Side-by-side comparison with known anti cancer agents
Finding targeted and novel synergistic combinations
Science driven technology platforms
Short turnaround times
